Objectives: Despite the popularization of technology and the high penetration rate of smartphones and mobile devices, differences exist in the accessibility, utilization capabilities, and quality of technology depending on users’ characteristics. Since these discrepancies can threaten health information equity, popularization of medical information is essential. This review article examines domestic and international cases of popularization of medical information, and discusses the related issues, expectations, and practical measures to achieve the popularization of medical information. Methods: In this study, medical information was categorized as Electronic Health Records/Electronic Medical Records (EHR/EMRs; hospital-driven medical information), personal health records (PHRs; user-driven medical information), and patient-generated health data (PGHD; user-generated medical information [outside hospitals]). This article reviewed the domestic and international use status, acceptance rates, and use cases for each type of medical information. Issues and expectations about policies and cases related to the popularization of medical information were also described, and finally, practical measures to accomplish the popularization of medical information were discussed. Results: To achieve the popularization of medical information, the following measures should be considered: engaging health consumers to participate in the early stages of information production, cultivating digital literacy, producing easy-to-use and interesting medical content, visualizing health information, and creating a medical thesaurus. Conclusions Healthcare providers should make regular efforts to popularize medical information. The popularization of medical information is an essential process to achieve health equity and digital health equity.

Objectives: Despite the popularization of technology and the high penetration rate of smartphones and mobile devices, differences exist in the accessibility, utilization capabilities, and quality of technology depending on users’ characteristics. Since these discrepancies can threaten health information equity, popularization of medical information is essential. This review article examines domestic and international cases of popularization of medical information, and discusses the related issues, expectations, and practical measures to achieve the popularization of medical information. Methods: In this study, medical information was categorized as Electronic Health Records/Electronic Medical Records (EHR/EMRs; hospital-driven medical information), personal health records (PHRs; user-driven medical information), and patient-generated health data (PGHD; user-generated medical information [outside hospitals]). This article reviewed the domestic and international use status, acceptance rates, and use cases for each type of medical information. Issues and expectations about policies and cases related to the popularization of medical information were also described, and finally, practical measures to accomplish the popularization of medical information were discussed. Results: To achieve the popularization of medical information, the following measures should be considered: engaging health consumers to participate in the early stages of information production, cultivating digital literacy, producing easy-to-use and interesting medical content, visualizing health information, and creating a medical thesaurus. Conclusions Healthcare providers should make regular efforts to popularize medical information. The popularization of medical information is an essential process to achieve health equity and digital health equity.

Clear-cell sarcoma (CCS) is a rare soft tissue sarcoma that usually develops in the lower extremities of young adults. CCS of the gastrointestinal tract is extremely rare. We report here the first case of CCS of the stomach in Korea. A 28-year-old female developed a large tumor of the stomach that was initially considered Ewing sarcoma, based on the results of a needle biopsy. She had paraneoplastic syndrome; fever, anemia, and hyperglycemia. Follow-up abdominal computed tomography after four-cycles of chemotherapy with vincristine-doxorubicin-cyclophosphamide or ifosfamide-etoposide showed no tumor shrinkage and revealed a fistula between the tumor and the gastric lumen. The infected tumor prompted debulking surgery, which resulted in improvement of her symptoms. The pathologic findings were consistent with CCS, and fluorescence in situ hybridization for EWS gene rearrangement was positive, confirming the diagnosis. This case highlights the importance of clinical suspicion for CCS in chemotherapy-refractory Ewing sarcoma.
Adult ; Anemia ; Biopsy, Needle ; Diagnosis ; Drug Therapy ; Female ; Fever ; Fistula ; Fluorescence ; Follow-Up Studies ; Gastrointestinal Tract ; Gene Rearrangement ; Humans ; Hyperglycemia ; In Situ Hybridization ; Korea ; Lower Extremity ; Paraneoplastic Syndromes ; Sarcoma* ; Sarcoma, Clear Cell ; Sarcoma, Ewing ; Stomach* ; Young Adult

Echocardiographic diagnosis of atrial myxoma may not always be straightforward, and the distinction between myxoma and thrombi is not easy, especially when we observe a mass after successful surgery. Our report describes a 72-year-old woman who presented with right upper limb hemiparesis and was subsequently diagnosed as having transient ischemic attack due to a left atrial myxoma. One month after successful surgical resection of the tumor, the patient developed left-sided weakness. Echocardiography revealed a left atrial mass attached to the interatrial septum. Intravenous heparin was administered as a therapeutic trial for postoperative thrombi, which resulted in a decrease in mass size within a week. Anticoagulation with warfarin was continued, and complete resolution was demonstrated on a 4-month follow-up transesophageal echocardiography. This case highlights the fact that thrombus formation at the surgical site should be considered an unusual but potential complication after surgical resection of left atrial myxomas.
Aged ; Diagnosis ; Diagnosis, Differential* ; Echocardiography ; Echocardiography, Transesophageal ; Female ; Follow-Up Studies ; Heparin ; Humans ; Ischemic Attack, Transient ; Myxoma* ; Paresis ; Thrombosis* ; Upper Extremity ; Warfarin